Javad Shahidi
Geen lopende functies
Vermogen: 1 M $ op 30-04-2024
Profiel
Javad Shahidi worked as Vice President-Global Research & Development at Daiichi Sankyo, Inc. from 2019 to 2022.
He also worked as Chief Medical Officer at Centessa Pharmaceuticals Plc in 2022.
Prior to his professional experience, he earned a graduate degree from McGill University and a doctorate degree from Shahid Beheshti University of Medical Sciences.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-10-2022 | 158 932 ( 0.18% ) | 1 M $ | 30-04-2024 |
Eerdere bekende functies van Javad Shahidi
| Bedrijven | Functie | Einde |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Hoofd Techniek/Wetenschap/O&O | 14-10-2022 |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Hoofd Techniek/Wetenschap/O&O | 01-03-2022 |
Opleiding van Javad Shahidi
| McGill University | Graduate Degree |
| Shahid Beheshti University of Medical Sciences | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
